0001410384-20-000035.txt : 20200226 0001410384-20-000035.hdr.sgml : 20200226 20200226164924 ACCESSION NUMBER: 0001410384-20-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Offerdahl James CENTRAL INDEX KEY: 0001490198 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36350 FILM NUMBER: 20656545 MAIL ADDRESS: STREET 1: 11501 DOMAIN DRIVE STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q2 Holdings, Inc. CENTRAL INDEX KEY: 0001410384 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202706637 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 BUSINESS PHONE: 512-275-0072 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings, Inc. DATE OF NAME CHANGE: 20120103 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings Inc DATE OF NAME CHANGE: 20070821 4 1 wf-form4_158275374626448.xml FORM 4 X0306 4 2020-02-24 0 0001410384 Q2 Holdings, Inc. QTWO 0001490198 Offerdahl James 13785 RESEARCH BLVD. SUITE 150 AUSTIN TX 78750 1 0 0 0 Common Stock 2020-02-24 4 M 0 5480 13 A 13873 D Common Stock 2020-02-24 4 M 0 4520 24.89 A 18393 D Common Stock 2020-02-24 4 S 0 10000 82.06 D 8393 D Stock Option (right to buy) 13.0 2020-02-24 4 M 0 5480 0 D 2014-04-19 2024-03-19 Common Stock 5480.0 0 D Stock Option (right to buy) 24.89 2020-02-24 4 M 0 4520 0 D 2015-07-09 2022-06-09 Common Stock 4520.0 502 D Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.95 to $83.35 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option grant vested and became exercisable in equal monthly installments over 36 months beginning on April 19, 2014. The option grant vested and became exercisable in equal monthly installments over 36 months beginning on July 9, 2015. /s/ M. Scott Kerr, attorney-in-fact 2020-02-26